These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1117 related items for PubMed ID: 25175995

  • 1. Allosteric inhibition of g-protein coupled receptor oligomerization: strategies and challenges for drug development.
    Hurevich M, Talhami A, Shalev DE, Gilon C.
    Curr Top Med Chem; 2014; 14(15):1842-63. PubMed ID: 25175995
    [Abstract] [Full Text] [Related]

  • 2. Novel Allosteric Modulators of G Protein-coupled Receptors.
    Gentry PR, Sexton PM, Christopoulos A.
    J Biol Chem; 2015 Aug 07; 290(32):19478-88. PubMed ID: 26100627
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Bioluminescence Resonance Energy Transfer as a Method to Study Protein-Protein Interactions: Application to G Protein Coupled Receptor Biology.
    El Khamlichi C, Reverchon-Assadi F, Hervouet-Coste N, Blot L, Reiter E, Morisset-Lopez S.
    Molecules; 2019 Feb 01; 24(3):. PubMed ID: 30717191
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Oligomerization of GPCRs involved in endocrine regulation.
    Kleinau G, Müller A, Biebermann H.
    J Mol Endocrinol; 2016 Jul 01; 57(1):R59-80. PubMed ID: 27151573
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. GPCR structures in drug design, emerging opportunities with new structures.
    Tautermann CS.
    Bioorg Med Chem Lett; 2014 Sep 01; 24(17):4073-9. PubMed ID: 25086683
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Intracellular Receptor Modulation: Novel Approach to Target GPCRs.
    Ortiz Zacarías NV, Lenselink EB, IJzerman AP, Handel TM, Heitman LH.
    Trends Pharmacol Sci; 2018 Jun 01; 39(6):547-559. PubMed ID: 29653834
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. G protein-coupled receptor oligomerization revisited: functional and pharmacological perspectives.
    Ferré S, Casadó V, Devi LA, Filizola M, Jockers R, Lohse MJ, Milligan G, Pin JP, Guitart X.
    Pharmacol Rev; 2014 Jun 01; 66(2):413-34. PubMed ID: 24515647
    [Abstract] [Full Text] [Related]

  • 18. Hetero-oligomerization of chemokine receptors: diversity and relevance for function.
    Kraemer S, Alampour-Rajabi S, El Bounkari O, Bernhagen J.
    Curr Med Chem; 2013 Jun 01; 20(20):2524-36. PubMed ID: 23432589
    [Abstract] [Full Text] [Related]

  • 19. Molecular alliance-from orthosteric and allosteric ligands to dualsteric/bitopic agonists at G protein coupled receptors.
    Mohr K, Schmitz J, Schrage R, Tränkle C, Holzgrabe U.
    Angew Chem Int Ed Engl; 2013 Jan 07; 52(2):508-16. PubMed ID: 23225228
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 56.